Close
  Indian J Med Microbiol
 

Figure 2 Hydroxychloroquine (HCQ) retinopathy in the right (OD) and left (OS) eyes of a 62-year old female patient who was diagnosed with rheumatoid arthritis (RA) and had used HCQ for 20 years with a dose of 400 mg/day. Her uncorrected visual acuity (UCVA) was 0.6 LogMAR in both eyes and best-corrected visual acuity (BCVA) was 0.2 LogMAR in both eyes. Spectral domain optical coherence tomography (SD-OCT) ganglion cell analysis (a) reveals markedly reduced average, minimum, and sectorial ganglion cell complex (GCC) thickness in both eyes. Horizontal B scans (b) demonstrate disrupted parafoveal photoreceptor layer integrity in both eyes.

Figure 2 Hydroxychloroquine (HCQ) retinopathy in the right (OD) and left (OS) eyes of a 62-year old female patient who was diagnosed with rheumatoid arthritis (RA) and had used HCQ for 20 years with a dose of 400 mg/day. Her uncorrected visual acuity (UCVA) was 0.6 LogMAR in both eyes and best-corrected visual acuity (BCVA) was 0.2 LogMAR in both eyes. Spectral domain optical coherence tomography (SD-OCT) ganglion cell analysis (a) reveals markedly reduced average, minimum, and sectorial ganglion cell complex (GCC) thickness in both eyes. Horizontal B scans (b) demonstrate disrupted parafoveal photoreceptor layer integrity in both eyes.